Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, External ear inflammation, External ear pain, Inflammation, Rash
Clinical narrative: redness in the outside of my ears; red rash going down the back of my neck, which is around my spine; inflammation; rash is painful and hot; inflammation in the outside of my ears; pain in the outside of my ears; This spontaneous case was reported by a consumer and describes the occurrence of EXTERNAL EAR INFLAMMATION (inflammation in the outside of my ears), EXTERNAL EAR PAIN (pain in the outside of my ears), ERYTHEMA (redness in the outside of my ears), RASH ERYTHEMATOUS (red rash going down the back of my neck, which is around my spine), INFLAMMATION (inflammation) and RASH (rash is painful and hot) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced EXTERNAL EAR PAIN (pain in the outside of my ears) (seriousness criterion hospitalization). On an unknown date, the patient experienced EXTERNAL EAR INFLAMMATION (inflammation in the outside of my ears) (seriousness criterion hospitalization), ERYTHEMA (redness in the outside of my ears) (seriousness criterion hospitalization), RASH ERYTHEMATOUS (red rash going down the back of my neck, which is around my spine) (seriousness criterion hospitalization), INFLAMMATION (inflammation) (seriousness criterion hospitalization) and RASH (rash is painful and hot) (seriousness criterion hospitalization). The patient was treated with MELOXICAM for Adverse event, at a dose of 15 mg; PREDNISONE for Adverse event, at an unspecified dose and frequency; METHYLPREDNISOLONE for Adverse event, at a dose of 12 mg once a day; GABAPENTIN (NEURONTIN) for Adverse event, at a dose of 300 mg; ACETYLSALICYLIC ACID (BABY ASPIRIN) for Adverse event, at an unspecified dose and frequency and HYDROXYCHLOROQUINE for Adverse event, at a dose of 400 mg once a day. At the time of the report, EXTERNAL EAR INFLAMMATION (inflammation in the outside of my ears), EXTERNAL EAR PAIN (pain in the outside of my ears), ERYTHEMA (redness in the outside of my ears), RASH ERYTHEMATOUS (red rash going down the back of my neck, which is around my spine), INFLAMMATION (inflammation) and RASH (rash is painful and hot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient reports that she started taking meloxicam 15mg for a month when she couldn't tolerate the pain (as needed basis), then prednisone for 3 weeks. The patient was also prescribed and is currently taking methylprednisolone 12mg daily, Neurontin 300mg, baby aspirin, and hydroxychloroquine 400mg daily  Company comment: This case concerns a 28 year-old, female with no relevant medical history reported, who experienced the unexpected events of EXTERNAL EAR INFLAMMATION, EXTERNAL EAR PAIN,  ERYTHEMA, RASH ERYTHEMATOUS, INFLAMMATION and RASH . The event soccurred approximately 5 days after the first dose of mRNA-1273 Moderna vaccine.  The rechallenge is N/A (events didn´t resolve before 2nd shot, as per SD) The benefit-risk relationship of mRNA-1273 Moderna vaccine in not affected by this report.   This case was linked to MOD-2021-345575 (Patient Link).; Sender's Comments: This case concerns a 28 year-old, female with no relevant medical history reported, who experienced the unexpected events of EXTERNAL EAR INFLAMMATION, EXTERNAL EAR PAIN,  ERYTHEMA, RASH ERYTHEMATOUS, INFLAMMATION and RASH . The event soccurred approximately 5 days after the first dose of mRNA-1273 Moderna vaccine.  The rechallenge is N/A (events didn´t resolve before 2nd shot, as per SD) The benefit-risk relationship of mRNA-1273 Moderna vaccine in not affected by this report.